|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Urigen N.A. Appoints Terry M. Nida To Chief Operating Officer
11/29/2006 12:03:00 PM
BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen N.A., Inc. has promoted Terry M. Nida to Chief Operating Officer.
Mr. Nida, aged 58, has 25 years of management experience in the pharmaceutical industry. Since May 2006, he has served as Vice President of Worldwide Sales, Marketing and Corporate Development at Urigen. Prior to joining Urigen, he held the position of Vice President at VIVUS Inc., a pharmaceutical company dedicated to the development and commercialization of therapeutic products, where he was responsible for worldwide corporate development, sales and marketing. Prior to Vivus, Mr. Nida served as Senior Director of Worldwide Sales, Marketing and Business Development for Centocor, Inc., a leader in monoclonal antibody production and technology and a wholly owned subsidiary of Johnson & Johnson. His past work experience also includes positions in sales and marketing at Bristol Laboratories, a division of Bristol Myers, and a distinguished military career.
|
|
|
|
|
|
|
|
|
|
|